Hsbc Holdings PLC Buys 40,063 Shares of Alignment Healthcare, Inc. $ALHC

Key Points

• Hsbc Holdings PLC increased its stake in Alignment Healthcare, Inc. by 254.5%, acquiring an additional 40,063 shares, bringing its total ownership to 55,806 shares valued at approximately $1,027,000.
• Alignment Healthcare reported a 49.0% year-over-year revenue increase, reaching $1.02 billion for the quarter, beating analysts' expectations.
• Institutional investors hold 86.19% of Alignment Healthcare's shares, indicating strong institutional confidence in the company.

Hsbc Holdings PLC raised its position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 254.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 55,806 shares of the company's stock after purchasing an additional 40,063 shares during the period. Hsbc Holdings PLC's holdings in Alignment Healthcare were worth $1,027,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. MCF Advisors LLC increased its position in shares of Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after acquiring an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in Alignment Healthcare during the first quarter worth $42,000. Amalgamated Bank increased its holdings in Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after buying an additional 616 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after buying an additional 6,286 shares during the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in Alignment Healthcare during the fourth quarter worth $189,000. Institutional investors own 86.19% of the company's stock.

Insider Activity

In other news, President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $13.44, for a total transaction of $403,200.00. Following the sale, the president directly owned 2,042,899 shares in the company, valued at $27,456,562.56. This represents a 1.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Christopher J. Joyce sold 15,491 shares of Alignment Healthcare stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $16.01, for a total value of $248,010.91. Following the sale, the insider owned 374,531 shares of the company's stock, valued at approximately $5,996,241.31. This trade represents a 3.97% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 636,185 shares of company stock valued at $9,235,468. 6.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ALHC. Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their target price for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a report on Monday, August 25th. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $18.83.

Alignment Healthcare Stock Up 1.7%

ALHC stock traded up $0.28 during trading on Tuesday, reaching $16.64. The stock had a trading volume of 3,583,120 shares, compared to its average volume of 3,005,335. Alignment Healthcare, Inc. has a one year low of $8.65 and a one year high of $21.06. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The company's 50 day moving average is $13.98 and its two-hundred day moving average is $15.37. The company has a market capitalization of $3.30 billion, a price-to-earnings ratio of -59.43 and a beta of 1.17.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The firm's quarterly revenue was up 49.0% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.